key: cord-0778785-xxptms0v
authors: Iftner, T.; Iftner, A.; Pohle, D.; Martus, P.
title: Evaluation of the specificity and accuracy of SARS-CoV-2 rapid antigen self-tests compared to RT-PCR from 1015 asymptomatic volunteers
date: 2022-02-13
journal: nan
DOI: 10.1101/2022.02.11.22270873
sha: 6a0ea47a28460162b95649842c5165ef3bc7e581
doc_id: 778785
cord_uid: xxptms0v

Objective Evaluation of the specificity and accuracy of four CE-approved SARS-CoV-2 antigen rapid self-tests (AG-ST) Anbio, Clungene, Hotgene and Mexacare. Method 1015 asymptomatic volunteers were screened for SARS-CoV-2 by means of an oropharyngeal swab taken by qualified personnel and subsequent RT-PCR testing. Each participant additionally performed nasal self-swabs for two of the four rapid antigen tests at the same day according to the manufacturers instructions. Study participants transmitted a photo and own interpretation of their test results to the study center. The results of the two self-tests provided by the participants were correlated with the results of the SARS-CoV-2 RT-PCR and independently assessed and evaluated by the study center. Results None of the volunteers tested positive upon RT-PCR, whereas 13 AG-ST showed a false positive test result (0.7%). The highest false positivity rate was found for the Clungene test (2.1% compared to 0.2% for the other tests), while the highest test failure rate (invalid) was found for the Mexacare test (3.7%). The Anbio and Hotgene tests produced the fewest false positive results when evaluated by the participants and also showed the best agreement among themselves. Conclusion SARS-CoV-2 Antigen rapid self- tests with higher false positive test rates, such as the Clungene test, or with high rates of invalid test results, such as the Mexacare test, are less suitable for screening purposes of asymptomatic study participants especially in low-prevalence settings. False positive or inadequate test results increase the burden on certified test laboratories due to verification PCR tests and cause a substantial economic loss due to unnecessary quarantine measurements and cause psychological stress in the affected study participants. In addition to earlier defined requirements for sensitivity for SARS-CoV-2 detection, a lower acceptance boundary for the false positivity rate of < 0.3% should be demanded.

CoV-2 are available on the European market. Most of them are based on lateral flow immunochromatography and target the viral nucleoprotein (N) in respiratory samples, or, rarely, the spike protein (S). A number of different SARS-CoV-2 variants, including variants of concern (VOC) and variants of interest (VOI) have been transmitted worldwide. Since mutations primarily affect the S and ORF1a/b genes (1, 2), the vast majority of SARS-CoV-2 AG-ST using the N-antigen for detection are unaffected by these genetic changes. RT-PCR or transcription-mediated amplification (TMA) are the gold standard for SARS-CoV-2 detection.

With a high level of sensitivity and specificity, they are able to detect SARS-CoV-2 at very early and very late stages of infection (3, 4) . Nevertheless, as high viral loads are usually present during the early phase of viral infection in nasal and oropharyngeal samples, especially for the latest VOCs delta and omicron (5) (6) (7) , certified AG-ST represent an important instrument in the control of the pandemic outbreak of SARS-CoV-2 and its variants.

The German state of Baden-Wuerttemberg (BW) has been distributing up to 3.5 million self-tests per week from various manufacturers since April 2021. For some of these self-tests, a conspicuously high number of false-positive results has sporadically been self-reported by . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270873 doi: medRxiv preprint the users, especially from primary and secondary schools. A self-test conducted under the guidance of or supervision by a trained third party will immediately result in the quarantine of the tested person and requires a confirmation via RT-PCR. In contrast, a positive result of a non-supervised self-test does not lead to quarantine, but establishes an obligation to retest by means of PCR diagnostics. Thus, false-positive results have far-reaching consequences with regard to the obligation to quarantine and lead to an additional burden on PCR capacities.

However, data are scarce on the performance of these AG self-tests in real life scenarios.

In the European Union (EU), regulatory requirements for SARS-CoV-2 in vitro diagnostic (IVD) devices are defined in the IVD Directive 98/79/EC (IVD) (8) and such devices must have a certification (CE label) issued by the manufacturer before being allowed to be distributed at the EU common market. Exceptions are however possible because of the high dynamics of the pandemic situation as by comparison to the performance of a similar test for professional use such as the same antigen test for medical professionals. As AG-STs allow the rapid identification of acutely infected individuals by self-testing and thereby help to interrupt infection chains, they facilitate quick measures such as containment, isolation of patients in hospitals, and prevention of infection events via Health Care Workers (HCW). In addition, AG-STs can help to save limited reagents for RT-qPCR or TMA in diagnostic labs for symptomatic individuals (9, 10) .

In a recent publication by Scheiblauer and colleagues (11) , the sensitivities of different AG tests were determined for 122 CE-labeled antigen tests with a defined limit of a minimum sensitivity of 75 % in samples with Cycle threshold (Ct) values less than 25 cycles using a panel of diagnostic samples that had been collected by medical professionals and had been analyzed by SARS-CoV-2 RT-PCR before. This requirement was fullfilled by 96/122 tests, including tests from Teda (Anbio), Hotgen, and Clongene. Others, such as Mexacare's test (sensitivity of . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270873 doi: medRxiv preprint 52.9 %) did not reach the sensitivity criterion. The data suggest a good suitability of a number of tests, but should be considered critically due to missing confidence intervals for the reported sensitivities. Data on the accuracy and especially on the specificity of self-taken nasal swab antigen tests under real-life conditions compared to a gold standard such as RT-qPCR are, however, scarce.

We therefore attempted to collect those data with 1015 asymptomatic volunteers that 

Four different SARS-CoV-2 rapid antigen self-tests (AG-ST; Table 1) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 13, 2022. 138 test results could not be considered for further evaluation because 67 study participants did not provide a response (67 * 2 = 134 tests) ( Table 1 ). In addition, one test could not be performed (lack of fluid), one subject did not send in a photograph of the test, and one subject did not self-report the test result on the form (2 tests). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 13, 2022. ; 

In 97.4 % (1843/1892) of the test results, the study participants indicated a negative test result, in 0.7 % (13/1892), the test result was reported as "positive", and in 1.9 % (36/1892), the result was reported as "unclear" ( Table 2 ). An evaluation of the results revealed is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint To better assess the suitability for the "real-life setting" for each AG-ST, the number of false positive results reported by the study participants was weighted twice, and the number of unclear cases was weighted once to obtain a combined comparison parameter ( Table 3 ).

The lower this score, the fewer false positives and unclear results have been produced by the respective self-test. By using this weighting score, the two tests Mexacare and Clungene performed worse than Anbio and Hotgen; Anbio performed statistically significantly better than Clungene (p = 0.036) and Mexacare (p = 0.026). The other differences were within the range of random variation. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270873 doi: medRxiv preprint

The number of false positive rapid test results was highest for Clungene with 9 (concordance self-report and examiner = 90 %). The test Anbio, Hotgene and Mexacare each provided only one false positive result each, according to the self-testing person. However, this could not be confirmed during review by staff examiners. The highest number of unclear test results was observed with the AG-ST of Mexacare (18 cases) and Hotgene (10 cases by self-report and staff examiner). In contrast, the test result "unclear" was less frequent with the AG-ST Anbio and Clungene. 100.0 *The numbers achieved by the examiners were higher than the number by self-reports due to missing information provided by some study participants.

The test results "unclear" self-reported by the study participants were analyzed in more detail by the examiners (Table 6 ). While the study participants could only select between three choices to indicate the test result ("negative", "positive" and "unclear"), the examiners distinguished between "negative", "positive", "unclear" and "invalid". 4/36 tests self-reported as "unclear" were evaluated by the examiner as "negative" and 1/36 tests as "positive". One is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270873 doi: medRxiv preprint test result was also classified as "unclear" by the examiners. The majority of the "unclear" subject test results were, however, rated as "invalid" by the examiners because the control band was not visible on the test strip. With 18 cases, this occurred most frequently in the AG-ST Mexacare. Finally, study participants and staff examiners both listed problems or errors associated with the performance or evaluation of the tests (Table 7) . While a missing control band was reported in 18 cases, lack of test buffer, shifted or illegible detection areas were also reported. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270873 doi: medRxiv preprint

There is a clear correlation between the infectivity of SARS-CoV-2 and high viral loads in aerosols produced by acutely infected persons, independent of the presence or absence of symptoms (14) (15) (16) . Lateral flow immunoassays, commonly designated as rapid antigen tests (AG), are known to have a limited sensitivity, but are able to detect high viral loads in respiratory specimens. Thus, they are also commonly used for screening of asymptomatic individuals to detect infections to limit the spread of infection. For example, SARS-CoV-2 AG rapid self-tests (AG-ST) are used as part of a self-testing strategy in order to avoid that healthcare workers infected with SARS-CoV2 infect vulnerable groups at work. A large number of different AG-ST detecting the nuclear antigen of all known variants of SARS-CoV-2 are commercially available. Almost all of them state sensitivity values of > 92% and specificities of > 99.1% for PCR-confirmed specimens in their self-declared performance data, with which they would meet the quality requirements: sensitivity > 80 % for PCR-pos. and specificity > 97 % in a study population ≥ 100 persons (13). However, these self-declared performance data are often incorrect as recently shown in a study for test sensitivity of 122 CE-marked AG-ST (11) . In the study presented here, we wanted to investigate now the specificity of such tests and evaluate the frequency of handling and interpretation errors due to usage by nonprofessionals.

By screening 1015 asymptomatic volunteers for SARS-CoV-2 RNA and comparing this to AG-ST results, we could not confirm the self-reported specificity for one of four AG-ST tests, while specificity was acceptable for the other tree tests. In addition, some AG-ST may have an unacceptable high level of test result drop outs, e.g. due to illegible detection areas or missing control bands. In our present study, the highest false positivity rate was 2.1 % for the Clungene test, and the highest test failure rate (invalid) was 3.7 % for the Mexacare test. The Anbio and . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270873 doi: medRxiv preprint Hotgene tests produced the fewest false positives when used by study participants and also showed the best agreement among themselves. As none of the participants had a confirmed SARS-CoV-2 infection (i.e. RT-PCR was negative in all cases), it was not possible to investigate the sensitivity of the AG-ST. This was likely due to the very low SARS-CoV-2 prevalence in summer 2021. A potential limitation of the study might be a relatively high number of medical staff, e.g. participants likely were better trained to use AG-ST as the rest of the general population. Therefore, handling or interpretation errors could be underestimated in this cohort. As additional criteria might affect the performance of AG-ST it would have been useful to allow the user to describe in a free text field of the form sheet used to transfer the test results to the study center the possible source of interpretation errors, e.g. by lack of readability of the test, missing components in the kits etc.

In summary, our data show that the Clungene and Mexacare tests are probably less suitable for usage as antigen self-tests due to their high rate of false positive results and high number of unclear/invalid results, respectively. Tests with a high false-positivity rate should especially be avoided to be used in a population with a low prevalence of SARS-CoV-2.

SARS-CoV-2 Variant Classifications and Definitions

Temporal dynamics in viral shedding and transmissibility of COVID-19

Estimating infectiousness throughout SARS-CoV-2 infection course

The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients

Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant

Commission E. DIRECTIVE 98/79/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL Official Journal of the European Communities1998

Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR

Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis

Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen

(PEI) P-E-I. Minimum Criteria for Rapid SARS-CoV-2 Antigen Tests Pursuant to Section 1 para 1 Sentence 1 TestVO (Statutory Test Regulation): Rapid Antigen Tests www.pei.de: Paul-Ehrlich-Institut

Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2

Virological assessment of hospitalized patients with COVID-2019

Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19

We thank all participants enrolled in the study. We acknowledge A. Nothacker for organizing and conducting the clinical part and A. L. Bissinger for assistance with study protocol and ethics approval and Tina Ganzenmueller for critical reading of the manuscript. This work was supported by "Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg".We acknowledge support by Open Access Publishing Fund of University of Tübingen.